Abstract
Ventilator Associated Pneumonia (VAP) is a common nosocomial infection in the ICU. Diagnosis based on best available criteria remains difficult. Current and novel biomarkers have the potential to speed up and improve the accuracy of its diagnosis. This review highlights the markers that have gained the most attention to date and aims to discuss the challenges faced in introducing them at the bedside.
Keywords: Biomarker, C-reactive protein, diagnosis, elastin fibres, endotoxin, procalcitonin, triggering receptor expressed on myeloid cells-1, ventilator-associated pneumonia
Current Respiratory Medicine Reviews
Title:Biomarkers in the Diagnosis of Ventilator-Associated Pneumonia
Volume: 8 Issue: 3
Author(s): Vimal Grover, Neil Soni, Peter Kelleher and Suveer Singh
Affiliation:
Keywords: Biomarker, C-reactive protein, diagnosis, elastin fibres, endotoxin, procalcitonin, triggering receptor expressed on myeloid cells-1, ventilator-associated pneumonia
Abstract: Ventilator Associated Pneumonia (VAP) is a common nosocomial infection in the ICU. Diagnosis based on best available criteria remains difficult. Current and novel biomarkers have the potential to speed up and improve the accuracy of its diagnosis. This review highlights the markers that have gained the most attention to date and aims to discuss the challenges faced in introducing them at the bedside.
Export Options
About this article
Cite this article as:
Grover Vimal, Soni Neil, Kelleher Peter and Singh Suveer, Biomarkers in the Diagnosis of Ventilator-Associated Pneumonia, Current Respiratory Medicine Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339812800493296
DOI https://dx.doi.org/10.2174/157339812800493296 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Defensins: Key Molecules in Ocular Surface Protection
Current Immunology Reviews (Discontinued) Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain
Current Medicinal Chemistry Mechanisms of Neurovascular Dysfunction in Acute Ischemic Brain
Current Medicinal Chemistry The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents
Current Medicinal Chemistry - Central Nervous System Agents Diagnosis of Systemic Lupus Erythematosus in an Unusual Presentation: What a Primary Care Physician Should Know
Current Rheumatology Reviews Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research Structural Biology of Bacterial Secretion Systems in Gram-Negative Pathogens- Potential for New Drug Targets
Infectious Disorders - Drug Targets Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Occurrence of blaTEM and blaROB in Haemophilus species Causing Respiratory Tract Infections
Infectious Disorders - Drug Targets Pathogenesis of Central Nervous System Tuberculosis
Current Molecular Medicine DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
Current Pharmacogenomics Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews